AMERICAN CLINICAL LABORATORY ASSN for AMERICAN CLINICAL LABORATORY ASSN
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, COVID-19 test coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); regulation and oversight of clinical laboratories, including laboratory developed test services; commercial laboratory surge capacity issues for response to COVID-19 pandemic/epidemic/public health crises, access to clinical laboratory services via telehealth clinical visits. Saving Access to Laboratory Services Act H.R. 8188/S. 4449, VALID Act H.R. 4128/S. 2209, Telehealth Extension and Evaluation Act S. 3593, PREVENT Pandemics Act S. 3799, Consolidated Appropriations Act, 2023, P.L 117-328.
| Lobbyist | Covered position, as disclosed |
|---|---|
| HOLLY GROSHOLZ New | — |
| THOMAS B SPARKMAN | — |
| SUSAN VAN METER | — |
Medicare/Medicaid MMM
Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, COVID-19 test coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); regulation and oversight of clinical laboratories, including laboratory developed test services; commercial laboratory surge capacity issues for response to COVID-19 pandemic/epidemic/public health crises, access to clinical laboratory services via telehealth clinical visits. Saving Access to Laboratory Services Act H.R. 8188/S. 4449, VALID Act H.R. 4128/S. 2209, Telehealth Extension and Evaluation Act S. 3593, PREVENT Pandemics Act S. 3799, Consolidated Appropriations Act, 2023, P.L 117-328.
| Lobbyist | Covered position, as disclosed |
|---|---|
| HOLLY GROSHOLZ New | — |
| THOMAS B SPARKMAN | — |
| SUSAN VAN METER | — |
Budget/Appropriations BUD
Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, COVID-19 test coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); regulation and oversight of clinical laboratories, including laboratory developed test services; commercial laboratory surge capacity issues for response to COVID-19 pandemic/epidemic/public health crises, access to clinical laboratory services via telehealth clinical visits. Saving Access to Laboratory Services Act H.R. 8188/S. 4449, VALID Act H.R. 4128/S. 2209, Telehealth Extension and Evaluation Act S. 3593, PREVENT Pandemics Act S. 3799, Consolidated Appropriations Act, 2023, P.L 117-328.
| Lobbyist | Covered position, as disclosed |
|---|---|
| HOLLY GROSHOLZ New | — |
| THOMAS B SPARKMAN | — |
| SUSAN VAN METER | — |
Health Issues HCR
Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, COVID-19 test coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); regulation and oversight of clinical laboratories, including laboratory developed test services; commercial laboratory surge capacity issues for response to COVID-19 pandemic/epidemic/public health crises, access to clinical laboratory services via telehealth clinical visits. Saving Access to Laboratory Services Act H.R. 8188/S. 4449, VALID Act H.R. 4128/S. 2209, Telehealth Extension and Evaluation Act S. 3593, PREVENT Pandemics Act S. 3799, Consolidated Appropriations Act, 2023, P.L 117-328.
| Lobbyist | Covered position, as disclosed |
|---|---|
| HOLLY GROSHOLZ New | — |
| THOMAS B SPARKMAN | — |
| SUSAN VAN METER | — |
Disaster Planning/Emergencies DIS
Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, new test coding and pricing, COVID-19 test coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); regulation and oversight of clinical laboratories, including laboratory developed test services; commercial laboratory surge capacity issues for response to COVID-19 pandemic/epidemic/public health crises. Saving Access to Laboratory Services Act H.R. 8188/S. 4449, VALID Act H.R. 4128/S. 2209, PREVENT Pandemics Act S. 3799, Consolidated Appropriations Act, 2023, P.L 117-328.
| Lobbyist | Covered position, as disclosed |
|---|---|
| HOLLY GROSHOLZ New | — |
| THOMAS B SPARKMAN | — |
| SUSAN VAN METER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.